Cellular and molecular imaging of CAR-T cell-based immunotherapy
- 4 November 2023
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 203, 115135
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA262815, GM140929, HD107206, HL121365)
This publication has 118 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- 2-photon imaging of phagocyte-mediated T cell activation in the CNSJournal of Clinical Investigation, 2013
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Treating cancer with genetically engineered T cellsTrends in Biotechnology, 2011
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen ReceptorJournal of Immunotherapy, 2009
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In VivoMolecular Therapy, 2009
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- Mechanisms of specificity in protein phosphorylationNature Reviews Molecular Cell Biology, 2007
- Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB ActivationMolecular and Cellular Biology, 2006